Bogusław Maciejewski

Bogusław Maciejewski

Auto-generated profile, based on publicly available information

Bogusław Maciejewski

Maria Sklodowska-Curie National Research Institute of Oncology, Branch Gliwice, Gliwice, Poland

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
RSRafał Suwiński
Rafał Suwiński
MBMagdalena Bankowska-Wozniak
Magdalena Bankowska-Wozniak
WMWojciech Majewski
Wojciech Majewski
ASAnna Sowa
Anna Sowa
AIAdam Idasiak
Adam Idasiak
BMBoguslaw Maciejewski
Boguslaw Maciejewski

1 January 2001
Verified
Book Chapter
Closed access
PDF file
BMBogusław Maciejewski
Bogusław Maciejewski
LMLeszek Miszczyk
Leszek Miszczyk
RTRafal Tarnawski
Rafal Tarnawski
KSKrzysztof Składowski
Krzysztof Składowski

8 February 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GWGrzegorz Woźniak
Grzegorz Woźniak
TRTomasz Rutkowski
Tomasz Rutkowski
WMWojciech Majewski
Wojciech Majewski
ANAleksandra Napieralska
Aleksandra Napieralska
Jerzy WydmanskiJerzy Wydmanski
Jerzy Wydmanski
BMBogusław Maciejewski
Bogusław Maciejewski
The oral cancer treatment of choice is surgical excision with an organ preservation, if it is possible. Radiation therapy is commonly used as a postoperative treatment. Delivering radiation dose during surgery, defined as intraoperative radiotherapy (IORT), can be very useful especially in case of high risk of recurrence or where gross or macroscopic residual disease are present. The aim of this retrospective study is to evaluate the effectiveness of IORT combined with postoperative fractionated irradiation (EBRT) of patients with squamous cell carcinoma of the oral cavity. The study included 23 patients: IORT dose of 5–7.5 Gy was delivered using 50 kV X-rays generated by INTRABEAM™, combined with EBRT of 50–60 Gy in 25–30 fractions depending on presence of extracapsular invasion and narrow or positive surgical margins. Standard statistical tests were used. Median follow up was 64 months (range 8–222 months). The 5-year local tumour control was 92% and 82.5% in the 10-year follow-up. The 5-year overall survival (OS) was 56% and decreased to 45% during the next 5 years. There were no differences in the LTC, DFS and OS regarding sex, T-stage, grade and tumour localization, although a small group of analysed cases may raise some uncertainties. Acute side effects of combined IORT and EBRT were mild and no late complications occurred. The present study indicated that low-energy X-rays IORT combined with postoperative EBRT is a feasible and safe therapeutic modality which likely reduces a risk of locoregional recurrences.